May 12, 2014 / 11:15 AM / 3 years ago

CORRECTED-Allergan rejects Valeant Pharma's takeover bid

(Corrects date in paragraph 2 to April 22 from Aug. 22)

May 12 (Reuters) - U.S. medical firm Allergan Inc rejected the unsolicited takeover offer from Valeant Pharmaceuticals International Inc , saying it substantially undervalued the company.

Canada’s Valeant said on April 22 that it and activist investor Bill Ackman made an unsolicited $47 billion bid to buy Allergan.

Allergan, which makes the popular anti-wrinkle treatment Botox, also said on Monday it expected to increase its earnings per share by 20-25 percent and continue to generate double digit revenue growth in 2015. (Reporting by Esha Dey in Bangalore; Editing by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below